Suppression of tumorigenicity of glioblastoma cells by adenovirus- mediated MMAC1/PTEN gene transfer

Cancer Research

Volumn 58, Issue 11, 1998, Pages 2331-2334

  Cheney, I Wayne ^a   Johnson, Duane E ^a   Vaillancourt, Mei Ting ^a   Avanzini, Jenny ^a   Morimoto, Alyssa ^a   Demers, G William ^a   Wills, Ken N ^a   Shabram, Paul W ^a   Bolen, Joseph B ^a   Tavtigian, Sean V ^b   Bookstein, Robert ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE;

ADENOVIRUS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CHROMOSOME 10; GENE TRANSFER; GENETIC TRANSDUCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; CHROMOSOMES, HUMAN, PAIR 10; FLOW CYTOMETRY; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-TYROSINE-PHOSPHATASE; PTEN PHOSPHOHYDROLASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 15644369261     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Steck, P. A., Perhouse, M. A., Jassar, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumour suppressor gene, MMACI, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
2. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittman, M., Tycko, B., Hihshoosh, H., Wigler, M. H., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
3. Li, D-M., and Sun, H. TEPI, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res., 57: 2124-2129, 1997.
4. Cairns, P., Okami, K., Halachmi, S., Halachmi, N., Esteller, M., Herman, J. G., Jen, J., Isaacs, W. B., Bova, G. S., and Sidransky, D. Frequent inactivation of PTEN/ MMAC1 in primary prostate cancer. Cancer Res., 57: 4997-5000, 1997.
5. Teng D. H-F., Hu, R., Lin, H., Davis, T., Iliev, D., Frye, C., Swedlund, B., Hansen, K. L., Vinson, V. L., Gumpper, K. L., Ellis, L., El-Naggar, A., Frazier, M., Jassar, S., Langford, L. A., Lee, J., Mills, G. B., Perhouse, M. A., Pollack, R. E., Tornos, C., Troncoso, P., Yung, W. K. A., Fujii, G., Berson, A., Bookstein, R., Bolen, J. B., Tavtigian, S. V., and Steck, P. A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res., 57: 5221-5225, 1997.
6. Guldberg, P., Straten, P. T., Birck, A., Ahrenkiel, V., Kirkin, A. F., and Zeuthen, J. Disruption of the MMCA1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res., 57: 3660-3663, 1997.
7. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R., and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57: 3935-3940, 1997.
8. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. PTEN/MMAC1 mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
9. Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacocke, M., Eng, C., and Parsons, R. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet., 16: 64-67, 1997.
10. Nelen, M. R., Staveren, W. C. G. v., Peeters, E. A. J., Hassel, M. B., Gorlin, R. J., Hamm, H., Lindboe, C. G., Fryns, J-P., Sijmons, R. H., Woods, D. G., Mariman, E. C. M., Padberg, G. W., and Kremer, H. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet., 6: 1383-1387, 1997.
11. Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., and Eng, C. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat. Genet., 16: 333-334, 1997.
12. Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., and Tonks, N. K. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA, 94: 9052-9057, 1997.
13. Furnari, F. B., Lin, H., Huang, H-J. S., and Cavenee, W. K. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA, 94: 12479-12484, 1997.
14. Wills, K. N., Maneval, D. C., Menzel, P., Harris, M. P., Sutjipto, S., Vaillancourt, M-T., Huang, W-M., Johnson, D. E., Anderson, S. C., Wen, S-F., Bookstein, R., Shepard, H. M., and Gregory, R. J. Development and characterization of recombinant adenoviruses encoding p53 for gene therapy of cancer. Hum. Gene Ther., 5. 1079-1088, 1994.
15. Wang, J., Quo, K., Wills, K. N., and Walsh, K. Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res., 57: 351-354, 1997.
16. Huyghe, B. G., Liu, X-D., Sutjipto, S., Sugarman, B. J., Horn, M. T., Shepard, H. M., Scandella, C. J., and Shabram, P. Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography. Hum. Gene Ther., 6: 1403-1416. 1995.
17. Shanram, P. W., Giroux, D. D., Goudreau, A. M., Gregory, R. J., Horn, M. T., Huyghe, B. G., Liu, X-D., Nunnally, M. H., Sugarman, B. J., and Sutjipto, S. Analytical anion-exchange HPLC of recombinant type-5 adenoviral particles. Hum. Gene Ther., 8: 453-465, 1997.
18. Ponten, J., and Maciniyre, E. H. Long term culture of normal and neoplastic human glia. Acta Palhol. Microbiol. Scand., 74: 465-486, 1968.
19. Nyherg-Hoffman, C., Shabram, P., Li, W., Giroux, D., and Aguilar-Cordova, E. Sensitivity and reproducibility in adenoviral infectious titer determination. Nat. Med., 7: 808-811, 1997.
20. Harris, M. P., Sutjiplto, S., Wills, K. N., Hancock, W., Cornell, D., Johnson, D. E., Gregory, R. J., Shepard, H. M., and Maneval, D. C. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutanl p53 protein. Cancer Gene Ther., 3: 121-130, 1995.
21. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., Steck, P. A., Roth, J. A., MacDonnell, T. J., Steck, K. D., Levin, V. A., and Yung, W. K. Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res., 56: 694-699, 1996.
22. Kock, H., Harris, M. P., Anderson, S. C., Machemer, T., Hancock, W., Sutjipto, S., Wills, K. N., Gregory, R. J., Shepard, H. M., Westphal, M., and Maneval, D. C. Adenovirus-mtediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo. Int. J. Cancer, 67: 808-815, 1996.